Industry: Food & Beverages
Published Date: 2025-03-13
Pages: 90 Pages
Report ld: 4654346
Request Sample
Customized Report
The global market for Bifidus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
North American market for Bifidus is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bifidus is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bifidus include Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma, Shandong Zhongke Jiayi Bioengineering, Danone, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Bifidus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bifidus.
The Bifidus market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bifidus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bifidus manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm
Segment by Type
Food Grade
Pharmaceutical Grade
Segment by Application
Food & Beverages
Medicines
Health Products
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bifidus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bifidus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Bifidus Market Overview
1.1 Product Definition
1.2 Bifidus by Type
1.2.1 Global Bifidus Market Value Comparison by Type (2024 VS 2031)
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.3 Bifidus by Application
1.3.1 Global Bifidus Market Value by Application (2024 VS 2031)
1.3.2 Food & Beverages
1.3.3 Medicines
1.3.4 Health Products
1.3.5 Others
1.4 Global Bifidus Market Size Estimates and Forecasts
1.4.1 Global Bifidus Revenue 2020-2031
1.4.2 Global Bifidus Sales 2020-2031
1.4.3 Global Bifidus Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bifidus Market Competition by Manufacturers
2.1 Global Bifidus Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bifidus Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bifidus Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bifidus, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bifidus, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bifidus, Product Type & Application
2.7 Global Key Manufacturers of Bifidus, Date of Enter into This Industry
2.8 Global Bifidus Market Competitive Situation and Trends
2.8.1 Global Bifidus Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bifidus Players Market Share by Revenue
2.8.3 Global Bifidus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bifidus Market Scenario by Region
3.1 Global Bifidus Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bifidus Sales by Region: 2020-2031
3.2.1 Global Bifidus Sales by Region: 2020-2025
3.2.2 Global Bifidus Sales by Region: 2026-2031
3.3 Global Bifidus Revenue by Region: 2020-2031
3.3.1 Global Bifidus Revenue by Region: 2020-2025
3.3.2 Global Bifidus Revenue by Region: 2026-2031
3.4 North America Bifidus Market Facts & Figures by Country
3.4.1 North America Bifidus Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bifidus Sales by Country (2020-2031)
3.4.3 North America Bifidus Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bifidus Market Facts & Figures by Country
3.5.1 Europe Bifidus Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bifidus Sales by Country (2020-2031)
3.5.3 Europe Bifidus Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bifidus Market Facts & Figures by Region
3.6.1 Asia Pacific Bifidus Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bifidus Sales by Region (2020-2031)
3.6.3 Asia Pacific Bifidus Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bifidus Market Facts & Figures by Country
3.7.1 Latin America Bifidus Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bifidus Sales by Country (2020-2031)
3.7.3 Latin America Bifidus Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bifidus Market Facts & Figures by Country
3.8.1 Middle East and Africa Bifidus Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bifidus Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bifidus Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bifidus Sales by Type (2020-2031)
4.1.1 Global Bifidus Sales by Type (2020-2025)
4.1.2 Global Bifidus Sales by Type (2026-2031)
4.1.3 Global Bifidus Sales Market Share by Type (2020-2031)
4.2 Global Bifidus Revenue by Type (2020-2031)
4.2.1 Global Bifidus Revenue by Type (2020-2025)
4.2.2 Global Bifidus Revenue by Type (2026-2031)
4.2.3 Global Bifidus Revenue Market Share by Type (2020-2031)
4.3 Global Bifidus Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bifidus Sales by Application (2020-2031)
5.1.1 Global Bifidus Sales by Application (2020-2025)
5.1.2 Global Bifidus Sales by Application (2026-2031)
5.1.3 Global Bifidus Sales Market Share by Application (2020-2031)
5.2 Global Bifidus Revenue by Application (2020-2031)
5.2.1 Global Bifidus Revenue by Application (2020-2025)
5.2.2 Global Bifidus Revenue by Application (2026-2031)
5.2.3 Global Bifidus Revenue Market Share by Application (2020-2031)
5.3 Global Bifidus Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chr-Hansen
6.1.1 Chr-Hansen Company Information
6.1.2 Chr-Hansen Description and Business Overview
6.1.3 Chr-Hansen Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chr-Hansen Bifidus Product Portfolio
6.1.5 Chr-Hansen Recent Developments/Updates
6.2 DuPont
6.2.1 DuPont Company Information
6.2.2 DuPont Description and Business Overview
6.2.3 DuPont Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DuPont Bifidus Product Portfolio
6.2.5 DuPont Recent Developments/Updates
6.3 Wecare Probiotics
6.3.1 Wecare Probiotics Company Information
6.3.2 Wecare Probiotics Description and Business Overview
6.3.3 Wecare Probiotics Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wecare Probiotics Bifidus Product Portfolio
6.3.5 Wecare Probiotics Recent Developments/Updates
6.4 Probi
6.4.1 Probi Company Information
6.4.2 Probi Description and Business Overview
6.4.3 Probi Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Probi Bifidus Product Portfolio
6.4.5 Probi Recent Developments/Updates
6.5 Mitushi Bio Pharma
6.5.1 Mitushi Bio Pharma Company Information
6.5.2 Mitushi Bio Pharma Description and Business Overview
6.5.3 Mitushi Bio Pharma Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mitushi Bio Pharma Bifidus Product Portfolio
6.5.5 Mitushi Bio Pharma Recent Developments/Updates
6.6 Scitop Bio-tech
6.6.1 Scitop Bio-tech Company Information
6.6.2 Scitop Bio-tech Description and Business Overview
6.6.3 Scitop Bio-tech Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Scitop Bio-tech Bifidus Product Portfolio
6.6.5 Scitop Bio-tech Recent Developments/Updates
6.7 Lallemand
6.7.1 Lallemand Company Information
6.7.2 Lallemand Description and Business Overview
6.7.3 Lallemand Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lallemand Bifidus Product Portfolio
6.7.5 Lallemand Recent Developments/Updates
6.8 Goerlich Pharma
6.8.1 Goerlich Pharma Company Information
6.8.2 Goerlich Pharma Description and Business Overview
6.8.3 Goerlich Pharma Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Goerlich Pharma Bifidus Product Portfolio
6.8.5 Goerlich Pharma Recent Developments/Updates
6.9 Shandong Zhongke Jiayi Bioengineering
6.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
6.9.2 Shandong Zhongke Jiayi Bioengineering Description and Business Overview
6.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio
6.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments/Updates
6.10 Danone
6.10.1 Danone Company Information
6.10.2 Danone Description and Business Overview
6.10.3 Danone Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Danone Bifidus Product Portfolio
6.10.5 Danone Recent Developments/Updates
6.11 Shanghai SPH Sinopharm
6.11.1 Shanghai SPH Sinopharm Company Information
6.11.2 Shanghai SPH Sinopharm Description and Business Overview
6.11.3 Shanghai SPH Sinopharm Bifidus Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai SPH Sinopharm Bifidus Product Portfolio
6.11.5 Shanghai SPH Sinopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bifidus Industry Chain Analysis
7.2 Bifidus Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bifidus Production Mode & Process Analysis
7.4 Bifidus Sales and Marketing
7.4.1 Bifidus Sales Channels
7.4.2 Bifidus Distributors
7.5 Bifidus Customer Analysis
8 Bifidus Market Dynamics
8.1 Bifidus Industry Trends
8.2 Bifidus Market Drivers
8.3 Bifidus Market Challenges
8.4 Bifidus Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Bifidus market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 166
USD 4900.00
(Single User License)
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 111
USD 3950.00
(Single User License)
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 123
USD 2900.00
(Single User License)
The global Bifidus market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 152
USD 4900.00
(Single User License)
The global Bifidus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 95
USD 4250.00
(Single User License)
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 119
USD 3950.00
(Single User License)
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 89
USD 2900.00
(Single User License)
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 157
USD 4900.00
(Single User License)
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 131
USD 4350.00
(Single User License)
The global Bifidus market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 166
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 111
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 123
The global Bifidus market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 152
The global Bifidus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 95
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 119
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 89
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 157
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 131
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now